Nasogastric Tube Placement in Patients with Oesophageal Varices

Evidence-Based Safety Profile

The European Society for Clinical Nutrition and Metabolism (ESPEN) 2020 guidelines state that esophageal varices are no absolute contraindication for positioning a nasogastric tube (Grade 0 recommendation, 100% consensus) 1
The American Gastroenterological Association confirms that esophageal varices are not absolute contraindications to tube placement, though they can make site identification more difficult or place the patient at higher risk of aspiration 2
The European Association for the Study of the Liver (EASL) guidelines specify that naso-gastroenteric tubes are not contraindicated in patients with non-bleeding esophageal varices (Grade II-2, A1 recommendation) 2

The patient has non-bleeding varices (no active hemorrhage in the preceding 48-72 hours), making nasogastric tube placement feasible 2
The indication is gastric decompression for outlet obstruction, which is a primary indication for nasogastric tube placement 2
The patient requires nutritional support and has stable, non-bleeding varices, making nasogastric tube placement a viable option 1

Use adequate sedation with anesthesia support to aid in successful and safe nasogastric tube placement 2
Use fine-bore nasogastric tubes rather than large-bore tubes, as there is no evidence that fine-bore tubes pose unacceptable risk 1
Consider direct visualization or fluoroscopic guidance for difficult cases 2
Ensure the patient has been screened for active bleeding within the preceding 48-72 hours 2

Post-pyloric (jejunal) feeding bypasses varices entirely and may be preferred in high-risk patients 2
Percutaneous venting gastrostomy can be considered for prolonged decompression needs, though ascites should be drained first to reduce infectious complications 2
Avoid PEG tubes in cirrhotic patients due to bleeding risk 2

The Sengstaken-Blakemore or Minnesota tube is a different device entirely from a standard Ryle's tube and is specifically designed for treating active variceal bleeding, not for feeding or gastric decompression 3
These balloon tamponade devices achieve immediate control of bleeding in 50-92% of cases but are associated with major complications and 50% rebleeding rates 3
They should only be used as a bridge to definitive therapy (endoscopic treatment, TIPS) in cases of uncontrolled active variceal hemorrhage 3